True Wealth Design’s Tourmaline Bio TRML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-18
Closed -$861 2817
2025
Q3
$861 Hold
18
﹤0.01% 1805
2025
Q2
$288 Hold
18
﹤0.01% 1954
2025
Q1
$274 Buy
+18
New +$289 ﹤0.01% 1818

True Wealth Design's TRML Position: Q4 2025 in Review

True Wealth Design sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 18 shares — an estimated $861 sold.

True Wealth Design first reported a position in TRML in Q1 2025 and held it in 3 quarters. The position peaked at $861 in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • True Wealth Design reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • True Wealth Design sold 18 Tourmaline Bio shares in Q4 2025, an estimated $861.
  • True Wealth Design first reported a position in Tourmaline Bio in Q1 2025 and held it in 3 quarters.
  • True Wealth Design's Tourmaline Bio position peaked at $861 in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on True Wealth Design's 13F filing for Q4 2025, filed 8 Jan 2026.